We are live on
!
Find out more
PCM
Parsons Capital Management Portfolio holdings
AUM
$2.21B
1-Year Est. Return
28.12%
This Fund
S&P 500
This Quarter
Est. Return
-1.29%
1 Year Est. Return
+28.12%
3 Year Est. Return
+84.89%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.13%
AUM
$859M
AUM Growth
-$39.3M
(-4.4%)
Cap. Flow
-$20.3M
Cap. Flow
% of AUM
-2.37%
Top 10 Holdings %
Top 10 Hldgs %
30.57%
Holding
369
New
7
Increased
86
Reduced
199
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$5.71M |
| 2 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$1.08M |
| 3 |
Chevron
CVX
|
+$907K |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$739K |
| 5 |
Micron Technology
MU
|
+$725K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$9.55M |
| 2 |
Apple
AAPL
|
+$2.1M |
| 3 |
GE Aerospace
GE
|
+$1.91M |
| 4 |
ExxonMobil
XOM
|
+$1.55M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$884K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.75% |
| 2 | Industrials | 13.72% |
| 3 | Healthcare | 12.99% |
| 4 | Financials | 12.7% |
| 5 | Energy | 7.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JNCE
326
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $246K | 0.03% |
11,016
-32,000
| -74% | -$710K |
|
327
Healthcare Realty
HR
$6.84B
| $237K | 0.03% |
8,961
-575
| -6% | -$15.3K |
|
328
Rockwell Automation
ROK
$49B
| $235K | 0.03% |
1,350
| – | – |
|
|
LSI
329
DELISTED
Life Storage, Inc.
LSI
| $230K | 0.03% |
4,125
| – | – |
|
330
Revvity
RVTY
$12.8B
| $227K | 0.03% |
3,000
| – | – |
|
331
AllianceBernstein
AB
$3.47B
| $226K | 0.03% |
8,400
-3,000
| -26% | -$80K |
|
332
Oneok
OKE
$54.5B
| $226K | 0.03% |
3,965
| – | – |
|
|
CHK
333
DELISTED
Chesapeake Energy Corporation
CHK
| $224K | 0.03% |
370
-72
| -16% | -$48.3K |
|
334
Donaldson
DCI
$11.4B
| $223K | 0.03% |
4,950
| – | – |
|
335
Nutrien
NTR
$30.7B
| $222K | 0.03% |
+4,701
| New | +$235K |
|
|
COL
336
DELISTED
Rockwell Collins
COL
| $221K | 0.03% |
1,639
| – | – |
|
|
K
337
DELISTED
Kellanova
K
| $218K | 0.03% |
3,568
-80
| -2% | -$5.05K |
|
338
Hasbro
HAS
$13.2B
| $217K | 0.03% |
2,575
-400
| -13% | -$37.1K |
|
339
Goodyear
GT
$1.85B
| $214K | 0.02% |
8,035
| – | – |
|
340
J.M. Smucker
SJM
$12.8B
| $214K | 0.02% |
1,725
-700
| -29% | -$87.4K |
|
341
Invesco QQQ Trust
QQQ
$484B
| $209K | 0.02% |
+1,306
| New | +$216K |
|
342
iShares Core S&P US Value ETF
IUSV
$27.7B
| $207K | 0.02% |
+3,888
| New | +$215K |
|
|
VVC
343
DELISTED
Vectren Corporation
VVC
| $207K | 0.02% |
3,243
| – | – |
|
344
Enterprise Products Partners
EPD
$81.7B
| $205K | 0.02% |
8,380
+500
| +6% | +$13.3K |
|
345
Universal Display
OLED
$4.19B
| $205K | 0.02% |
2,031
+805
| +66% | +$121K |
|
346
Cardinal Health
CAH
$55.4B
| $201K | 0.02% |
+3,211
| New | +$220K |
|
|
DALN
347
DELISTED
DallasNews
DALN
| $155K | 0.02% |
7,500
| – | – |
|
|
TGEN
348
Tecogen Inc
TGEN
$116M
| $100K | 0.01% |
34,967
| – | – |
|
349
Aspen Aerogels
ASPN
$518M
| $49K | 0.01% |
11,500
| – | – |
|
350
Verastem
VSTM
$610M
| $43K | 0.01% |
1,208
| – | – |
|
Similar funds
WCMNY
IFA
DPCM
RAM
GC
ORCP
NP
GF
Parsons Capital Management's Q1 2018 Portfolio in Review
As of Q1 2018, Parsons Capital Management held 369 positions worth $859M, down 4.4% from $898M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Parsons Capital Management's Q1 2018 filing shows 7 new, 86 increased, 199 reduced and 15 closed positions. Its largest new stake was Micron Technology: 15,140 shares worth $789K. The largest sale was 3M, an estimated $9.55M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Healthcare.
- Parsons Capital Management's largest Q1 2018 buy was Micron Technology: 15,140 shares worth $789K.
- Parsons Capital Management added most to Berkshire Hathaway Class B in Q1 2018, an estimated $5.71M increase.
- Parsons Capital Management's biggest Q1 2018 reduction was 3M, cutting an estimated $9.55M.
- Parsons Capital Management fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $856K.
- Parsons Capital Management's ten largest holdings make up 31% of its $859M portfolio in Q1 2018.
- Parsons Capital Management opened 7 new positions and closed 15 in Q1 2018.
- Parsons Capital Management's portfolio value fell 4.4% quarter-over-quarter to $859M.
Based on Parsons Capital Management's 13F filing for Q1 2018, filed 7 May 2018.